DERMATOLOGY

 
Dermatology trials carry some very unique challenges. From retention difficulties to compliance issues in a patient population that is on average much younger than the norm. Biorasi knows how to make your dermatology trial a success.

Overcoming Complex Dermatology Trial Challenges

Dermatology continues to be on the target list for innovation and product development. Although many consider dermatology to be a simple therapeutic area to tackle, Biorasi understands the unique challenges that still exist. Attracting and enrolling patients can be straightforward, but retaining them throughout a study can be especially difficult. Particularly when working with the skin, the body’s largest organ, environmental and seasonal factors can easily disrupt a patient’s treatment. Acknowledging these and other similar challenges up front and properly factoring them in to trial design is key for trial success.

Dermatology Experience for Dermatology Trial Success

Biorasi’s most recent dermatology experience includes acne, rosacea and psoriasis and many others. Our strategy for success involves leveraging our proprietary site database to select high-performing sites whose primary investigators are up to date on the latest treatments, assessments and clinical scales. We focus on proper patient screening and education, especially when dealing with a younger demographic, to promote compliance and retention. This experience, along with our exceptional clinical team, gives Biorasi the tools to effectively deliver concise solutions for Dermatology trials across the globe.

"One of the rarest events, where we had to communicate [to Biorasi] to stop the screening rather than boost it."

VP of Global Clinical Development, Top Specialty Pharma
 

Latest News and Blogs

Why Aren’t There Any FDA-Approved Drugs to Treat NASH?

The liver does many important things in the body, such as filtering of the blood and metabolizing all compounds, including food and drugs, that enter the body. In that vein, liver disease can be absolutely devastating.   Non-alcoholic fatty liver disease (NAFLD)...

10 Lessons On Success in Asia-PAC Trials from DIA 2018

Earlier this year, a few of us attended DIA 2018 to represent Biorasi. While there, we were fortunate enough to be able to give a talk about some of our experiences entitled “Balancing Unity and Individuality: Leadership Skills for Managing Culturally Divergent...

Contact Biorasi

13 + 15 =